Clinical Social Workers in Tempe, AZ Accepting Medicare
127 Clinical Social Workers found. Showing 121 - 127
 Kathleen Gerilyn Sullivan, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 1835 E Guadalupe Rd Ste 103, Tempe, AZ 85283 Phone: 480-287-1967 |
Ms. Jacci Arden Caplin, MSW, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2 W Dawn Dr, Tempe, AZ 85284 Phone: 480-707-7790 |
Letty Martinez Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2120 S Mcclintock Dr, Suite 105, Tempe, AZ 85282 Phone: 480-804-0326 Fax: 480-302-7884 |
Shana Lynn Thompson Smith Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 618 S Madison Dr, Tempe, AZ 85281 Phone: 480-784-1514 Fax: 480-736-4939 |
 Mr. William Lowell Bradley, M.S.W. Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 2101 E Broadway Rd, #25, Tempe, AZ 85282 Phone: 480-921-3711 Fax: 480-921-0307 |
Kelli Friedel Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 2168 E Sanos Dr, Tempe, AZ 85281 Phone: 785-477-7363 |
Jessica Kenny Clinical Social Worker Medicare: Medicare Enrolled Practice Location: 1400 E Southern Ave Ste 735, Tempe, AZ 85282 Phone: 480-804-0326 |
News Archive
Blood vessel plug - amplatzer ductal occluder, performs well in trial
In the largest and longest trial yet of a device called the Amplatzer ductal occluder, a duct that shunts blood flow away from the lungs during fetal development but sometimes fails to close after birth, was successfully closed in almost all patients, according to a new study in the Aug. 4, 2004, issue of the Journal of the American College of Cardiology.
Scientists discover mechanism used by A20 protein to combat inflammation
Scientists affiliated with VIB and UGent have discovered a mechanism used by the protein A20 to combat inflammation. This could be a very important point of focus in the search for a treatment for autoimmune diseases such as Rheumatoid Arthritis, in which the patient suffers from chronic, uncontrolled inflammation.
Shire collaborates with Santaris Pharma to develop Locked Nucleic Acid technology
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, announces today that it has entered into a research-based collaboration with Santaris Pharma A/S, a leading player in RNA-based therapeutics, to develop its proprietary Locked Nucleic Acid (LNA) technology in a range of rare diseases, thereby enabling Shire to build on its already strong competitive position for its Human Genetic Therapies (HGT) business.
FDA gives marketing clearance for new device that helps doctors to accurately assess children's weight
The Emmes Corporation today announced that the U.S. Food and Drug Administration has given marketing clearance for a new device that allows doctors to more accurately assess children's weight without the use of a weight scale. Weight estimates are used in emergency situations and in developing countries where scales may not be available.
e-Health identifiers for Australians to be allocated next week
The new Australian electronic healthcare database service has been on the cards for a while now. The legislation that flags off this scheme passed in the federal parliament and may be implemented next week on 1st July. This will ensure that every Australian is given a unique healthcare identification number. Doctors, hospitals, healthcare organisations and allied health providers will receive similar identifiers.
› Verified 4 days ago
Counselors
Pharmacists
Dentists
Clinical Social Workers
Psychologists
Occupational Therapists